JP2023547887A5 - - Google Patents

Info

Publication number
JP2023547887A5
JP2023547887A5 JP2023525019A JP2023525019A JP2023547887A5 JP 2023547887 A5 JP2023547887 A5 JP 2023547887A5 JP 2023525019 A JP2023525019 A JP 2023525019A JP 2023525019 A JP2023525019 A JP 2023525019A JP 2023547887 A5 JP2023547887 A5 JP 2023547887A5
Authority
JP
Japan
Prior art keywords
cells
cell
manipulated
chr11
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023525019A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023547887A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/056689 external-priority patent/WO2022093846A1/en
Publication of JP2023547887A publication Critical patent/JP2023547887A/ja
Publication of JP2023547887A5 publication Critical patent/JP2023547887A5/ja
Pending legal-status Critical Current

Links

JP2023525019A 2020-10-26 2021-10-26 セーフハーバー遺伝子座 Pending JP2023547887A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202063105834P 2020-10-26 2020-10-26
US63/105,834 2020-10-26
US202163141926P 2021-01-26 2021-01-26
US63/141,926 2021-01-26
US202163179143P 2021-04-23 2021-04-23
US63/179,143 2021-04-23
PCT/US2021/056689 WO2022093846A1 (en) 2020-10-26 2021-10-26 Safe harbor loci

Publications (2)

Publication Number Publication Date
JP2023547887A JP2023547887A (ja) 2023-11-14
JP2023547887A5 true JP2023547887A5 (https=) 2024-11-05

Family

ID=81383221

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023525019A Pending JP2023547887A (ja) 2020-10-26 2021-10-26 セーフハーバー遺伝子座

Country Status (15)

Country Link
EP (1) EP4232049A4 (https=)
JP (1) JP2023547887A (https=)
KR (1) KR20230101839A (https=)
AU (1) AU2021369494A1 (https=)
BR (1) BR112023007874A2 (https=)
CA (1) CA3196269A1 (https=)
CL (1) CL2023001176A1 (https=)
CO (1) CO2023006809A2 (https=)
CR (1) CR20230220A (https=)
DO (2) DOP2023000080A (https=)
IL (1) IL302315A (https=)
MX (1) MX2023004822A (https=)
PE (1) PE20231514A1 (https=)
WO (1) WO2022093846A1 (https=)
ZA (1) ZA202402949B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2023002455A (es) * 2020-08-28 2023-05-16 Arsenal Biosciences Inc Células inmunitarias modificadas con receptores cebadores.
JP2024537991A (ja) 2021-10-14 2024-10-18 アーセナル バイオサイエンシズ インコーポレイテッド 共発現されるｓｈＲＮＡと論理ゲートシステムとを有する免疫細胞
CN115896227A (zh) * 2022-12-20 2023-04-04 西北农林科技大学 一种鉴定外源基因整合位点以增强转基因表达的方法
IL322949A (en) 2023-03-03 2025-10-01 Arsenal Biosciences Inc Systems targeting PSMA and CA9

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
US20070161031A1 (en) * 2005-12-16 2007-07-12 The Board Of Trustees Of The Leland Stanford Junior University Functional arrays for high throughput characterization of gene expression regulatory elements
US9255250B2 (en) * 2012-12-05 2016-02-09 Sangamo Bioscience, Inc. Isolated mouse or human cell having an exogenous transgene in an endogenous albumin gene
KR20250141836A (ko) * 2015-11-04 2025-09-29 페이트 세러퓨틱스, 인코포레이티드 만능 세포의 유전자 조작
MA52116A (fr) * 2018-03-02 2021-01-06 Generation Bio Co Vecteurs d'adn à extrémité fermée (cedna) pour l'insertion de transgènes au niveau de havres génomiques sécuritaires (gsh) dans des génomes humains et murins
CN113227374A (zh) * 2018-10-16 2021-08-06 因特利亚治疗公司 用于免疫疗法的组合物和方法
MX2023002455A (es) * 2020-08-28 2023-05-16 Arsenal Biosciences Inc Células inmunitarias modificadas con receptores cebadores.
JP2024537991A (ja) * 2021-10-14 2024-10-18 アーセナル バイオサイエンシズ インコーポレイテッド 共発現されるｓｈＲＮＡと論理ゲートシステムとを有する免疫細胞

Similar Documents

Publication Publication Date Title
JP2023547887A5 (https=)
AU2018355587B2 (en) Targeted replacement of endogenous T cell receptors
JP2023055884A5 (https=)
AU2016276702B2 (en) CRISPR/CAS-related methods and compositions for improving transplantation
JP2022512703A5 (https=)
US11761004B2 (en) Safe harbor loci
CN110139675A (zh) 用具有工程化稳定的内源性foxp3基因表达的cd4 t细胞治疗自身免疫疾病的方法
WO2016195598A1 (en) Vectors
JP2024502348A (ja) Ｔｒａｃｒ不含 Ｖ型Ｃａｓシステム用のガイドＲＮＡデザインおよび複合体
JP2023085547A (ja) ｓｎｏＲＮＡの発現抑制剤を有効成分とするがん増殖抑制剤
IL302315A (en) Secure port sites
CN105624196A (zh) 一种建立cyp2c11基因敲除大鼠模型的方法
TW201842923A (zh) 包含ｍｉｒ－３０２前驅體的組合物在製造用於肺癌治療之藥物上的用途
TW202417626A (zh) 具有共表現的ｔｇｆｂｒ ｓｈｒｎａ之免疫細胞
JP2022546302A (ja) ダンベル型ｄｎａベクターを作出するための方法
JP2025517469A (ja) 増殖依存性の遺伝子発現を示す、核酸で改変された生体細胞
US11053503B2 (en) Methods and means of generating IL-17 associated antitumor effector cells by inhibition of NR2F6 inhibition
CA3199435A1 (en) Methods of inducing antibody-dependent cellular cytotoxicity (adcc) using modified natural killer (nk) cells
US11883431B2 (en) T-cells modified to overexpress PHF19
TWI867731B (zh) 新的基因組安全港及其用途
EP4471143A1 (en) Mir-148a for use in the stimulation of t-cell anti-tumor response
WO2025049877A1 (en) Chemo-sensitive dominant clone for adaptive therapy
EA050294B1 (ru) Безопасный локус
CN120898000A (zh) 新的多核苷酸、细胞和方法
AR124287A1 (es) Linfocitos citolíticos naturales editados genéticamente